Did you know that cryptococcal meningitis is the second leading cause of death in people living with HIV, after TB? 180,000 people die every year due to cryptococcal meningitis, of which 135,000 are in sub-Saharan Africa. 70% of them could survive if they receive the right treatment combination. Together with scientists and institutions in Africa & Europe, we’re running a study in South Africa to develop an improved formulation of flucytosine, one of the key drugs used to treat this deadly disea

Treatment of cryptococcal meningitis typically includes 1 week of IV therapy with amphotericin B deoxycholate. However, this treatment carries a substantial risk of toxic effects. New research findings are summarized in a short video. https://nej.md/3wwjfrK | The New England Journal of Medicine